Genesis HealthCare Adjusts Q4 & 2015 Guidance; Issues Preliminary 2016 Outlook

(RTTNews) - Genesis HealthCare, Inc. (GEN) announced, for the three months ended December 31, 2015, the company expects: adjusted net revenues in the range of $1.41-$1.44 billion; adjusted EBITDA of $36.0-$42.0 million; and adjusted loss per share of $0.06-$0.04.

For the Twelve months Ended Dec. 31, 2015, the company expects: adjusted net revenue of $5.63-$5.66 billion; adjusted EBITDA of $246.0-$252.0 million; and adjusted earnings per share of $0.21-$0.23.

The company also announced it expects to deliver 6% year-over-year EBITDAR growth and more than 13% of EBITDA growth in 2016, building on its expected 2015 EBITDAR growth of 6% and EBITDA growth of nearly 14%. Adjusted net revenues are expected to grown 2% from midpoint of adjusted 2015 guidance. Adjusted earnings per share is expected to be between $0.19 to $$0.29.